Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,851 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Roles of tRNA-derived fragments in human cancers.
Sun C, Fu Z, Wang S, Li J, Li Y, Zhang Y, Yang F, Chu J, Wu H, Huang X, Li W, Yin Y. Sun C, et al. Among authors: chu j. Cancer Lett. 2018 Feb 1;414:16-25. doi: 10.1016/j.canlet.2017.10.031. Epub 2017 Oct 26. Cancer Lett. 2018. PMID: 29107107 Review.
Roles of cancer/testis antigens (CTAs) in breast cancer.
Li Y, Li J, Wang Y, Zhang Y, Chu J, Sun C, Fu Z, Huang Y, Zhang H, Yuan H, Yin Y. Li Y, et al. Among authors: chu j. Cancer Lett. 2017 Jul 28;399:64-73. doi: 10.1016/j.canlet.2017.02.031. Epub 2017 Mar 6. Cancer Lett. 2017. PMID: 28274891
EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties.
Li Y, Chu J, Feng W, Yang M, Zhang Y, Zhang Y, Qin Y, Xu J, Li J, Vasilatos SN, Fu Z, Huang Y, Yin Y. Li Y, et al. Among authors: chu j. FASEB J. 2019 Apr;33(4):4851-4865. doi: 10.1096/fj.201701561RRRR. Epub 2019 Jan 8. FASEB J. 2019. PMID: 30620624
Moreover, patients with HER2-positive breast cancers expressing high Notch1 activation and low EPHA5 expression could be the best candidates for anti-Notch1 therapy.-Li, Y., Chu, J., Feng, W., Yang, M., Zhang, Y., Zhang, Y., Qin, Y., Xu, J., Li, J., Va …
Moreover, patients with HER2-positive breast cancers expressing high Notch1 activation and low EPHA5 expression could be the best candidates …
3,851 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page